AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Litman, T Druley, TE Stein, WD Bates, SE
Citation: T. Litman et al., From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance, CELL MOL L, 58(7), 2001, pp. 931-959

Authors: Kang, MH Figg, WD Ando, Y Blagosklonny, MV Liewehr, D Fojo, T Bates, SE
Citation: Mh. Kang et al., The P-glycoprotein antagonist PSC 833 increases the plasma concentrations of 6 alpha-hydroxypaclitaxel, a major metabolite of paclitaxel, CLIN CANC R, 7(6), 2001, pp. 1610-1617

Authors: Mertins, SD Myers, TG Hollingshead, M Dykes, D Bodde, E Tsai, P Jefferis, CA Gupta, R Linehan, WM Alley, M Bates, SE
Citation: Sd. Mertins et al., Screening for and identification of novel agents directed at renal cell carcinoma, CLIN CANC R, 7(3), 2001, pp. 620-633

Authors: Robey, RW Medina-Perez, WY Nishiyama, K Lahusen, T Miyake, K Litman, T Senderowicz, AM Ross, DD Bates, SE
Citation: Rw. Robey et al., Overexpression of the ATP-binding cassette half-transporter, ABCG2 (MXR/BCRP/ABCP1), in flavopiridol-resistant human breast cancer cells, CLIN CANC R, 7(1), 2001, pp. 145-152

Authors: Honjo, Y Hrycyna, CA Yan, QW Medina-Perez, WY Robey, RW van de Laar, A Litman, T Dean, M Bates, SE
Citation: Y. Honjo et al., Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells, CANCER RES, 61(18), 2001, pp. 6635-6639

Authors: Piekarz, RL Robey, R Sandor, V Bakke, S Wilson, WH Dahmoush, L Kingma, DM Turner, ML Altemus, R Bates, SE
Citation: Rl. Piekarz et al., Inhibitor of histone deacetylation, depsipeptide (FR901228), in the treatment of peripheral and cutaneous T-cell lymphoma: a case report, BLOOD, 98(9), 2001, pp. 2865-2868

Authors: Robey, RW Honjo, Y van de Laar, A Miyake, K Regis, JT Litman, T Bates, SE
Citation: Rw. Robey et al., A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2), BBA-BIOMEMB, 1512(2), 2001, pp. 171-182

Authors: Pirnia, F Breuleux, M Schneider, E Hochmeister, M Bates, SE Marti, A Hotz, MA Betticher, DC Borner, MM
Citation: F. Pirnia et al., Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53, J NAT CANC, 92(18), 2000, pp. 1535-1536

Authors: Sandor, V Robbins, AR Robey, R Myers, T Sausville, E Bates, SE Sackett, DL
Citation: V. Sandor et al., FR901228 causes mitotic arrest but does not alter microtubule polymerization, ANTI-CANC D, 11(6), 2000, pp. 445-454

Authors: Bouziane, M Miao, F Bates, SE Somsouk, L Sang, BC Denissenko, M O'Connor, TR
Citation: M. Bouziane et al., Promoter structure and cell cycle dependent expression of the human methylpurine-DNA glycosylase gene, MUT R-DNA R, 461(1), 2000, pp. 15-29

Authors: Wosikowski, K Silverman, JA Bishop, P Mendelsohn, J Bates, SE
Citation: K. Wosikowski et al., Reduced growth rate accompanied by aberrant epidermal growth factor signaling in drug resistant human breast cancer cells, BBA-MOL CEL, 1497(2), 2000, pp. 215-226

Authors: Litman, T Brangi, M Hudson, E Fetsch, P Abati, A Ross, DD Miyake, K Resau, JH Bates, SE
Citation: T. Litman et al., The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2), J CELL SCI, 113(11), 2000, pp. 2011-2021

Authors: Blagosklonny, MV Bishop, PC Robey, R Fojo, T Bates, SE
Citation: Mv. Blagosklonny et al., Loss of cell cycle control allows selective microtubule-active drug-induced Bcl-2 phosphorylation and cytotoxicity in autonomous cancer cells, CANCER RES, 60(13), 2000, pp. 3425-3428

Authors: Sandor, V Senderowicz, A Mertins, S Sackett, D Sausville, E Blagosklonny, MV Bates, SE
Citation: V. Sandor et al., P21-dependent G(1) arrest with downregulation of cyclin D1 and upregulation of cyclin E by the histone deacetylase inhibitor FR901228, BR J CANC, 83(6), 2000, pp. 817-825

Authors: Rocchi, E Khodjakov, A Volk, EL Yang, CH Litman, T Bates, SE Schneider, E
Citation: E. Rocchi et al., The product of the ABC half-transporter gene ABCG2 (BCRP/MXR/ABCP) is expressed in the plasma membrane, BIOC BIOP R, 271(1), 2000, pp. 42-46

Authors: Bates, SE
Citation: Se. Bates, Drug resistance: Still on the learning curve, CLIN CANC R, 5(11), 1999, pp. 3346-3348

Authors: de Bruin, M Miyake, K Litman, T Robey, R Bates, SE
Citation: M. De Bruin et al., Reversal of resistance by GF120918 in cell lines expressing the ABC half-transporter, MXR, CANCER LETT, 146(2), 1999, pp. 117-126

Authors: Gamelin, E Mertins, SD Regis, JT Mickley, L Abati, A Worrell, RA Linehan, WM Bates, SE
Citation: E. Gamelin et al., Intrinsic drug resistance in primary and metastatic renal cell carcinoma, J UROL, 162(1), 1999, pp. 217-224

Authors: Bates, SE Gurney, AM
Citation: Se. Bates et Am. Gurney, Use-dependent facilitation and depression of L-type Ca2+ current in guinea-pig ventricular myocytes: modulation by Ca2+ and isoprenaline, CARDIO RES, 44(2), 1999, pp. 381-389

Authors: Brangi, M Litman, T Ciotti, M Nishiyama, K Kohlhagen, G Takimoto, C Robey, R Pommier, Y Fojo, T Bates, SE
Citation: M. Brangi et al., Camptothecin resistance: Role of the ATP-binding cassette (ABC), mitoxantrone-resistance half-transporter (MXR), and potential for glucuronidation inMXR-expressing cells, CANCER RES, 59(23), 1999, pp. 5938-5946

Authors: Miyake, K Mickley, L Litman, T Zhan, ZR Robey, R Cristensen, B Brangi, M Greenberger, L Dean, M Fojo, T Bates, SE
Citation: K. Miyake et al., Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: Demonstration of homology to ABC transport genes, CANCER RES, 59(1), 1999, pp. 8-13

Authors: Bates, SE Zhan, ZR Regis, J Gamelin, E
Citation: Se. Bates et al., Measuring MDR-1 by quantitative RT-PCR, METH MOL M, 28, 1999, pp. 63-81
Risultati: 1-22 |